Cargando…

Tumour location within the breast: Does tumour site have prognostic ability?

INTRODUCTION: Tumour location within the breast varies with the highest frequency in the upper outer quadrant (UOQ) and lowest frequency in the lower inner quadrant (LIQ). Whether tumour location is prognostic is unclear. To determine whether tumour location is prognostic, associations between tumou...

Descripción completa

Detalles Bibliográficos
Autores principales: Rummel, Seth, Hueman, Matthew T, Costantino, Nick, Shriver, Craig D, Ellsworth, Rachel E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cancer Intelligence 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4531129/
https://www.ncbi.nlm.nih.gov/pubmed/26284116
http://dx.doi.org/10.3332/ecancer.2015.552
_version_ 1782384990407884800
author Rummel, Seth
Hueman, Matthew T
Costantino, Nick
Shriver, Craig D
Ellsworth, Rachel E
author_facet Rummel, Seth
Hueman, Matthew T
Costantino, Nick
Shriver, Craig D
Ellsworth, Rachel E
author_sort Rummel, Seth
collection PubMed
description INTRODUCTION: Tumour location within the breast varies with the highest frequency in the upper outer quadrant (UOQ) and lowest frequency in the lower inner quadrant (LIQ). Whether tumour location is prognostic is unclear. To determine whether tumour location is prognostic, associations between tumour site and clinicopathological characteristics were evaluated. MATERIALS AND METHODS: All patients enrolled in the Clinical Breast Care Project whose tumour site—UOQ, upper inner quadrant (UIQ), central, LIQ, lower outer quadrant (LOQ)—was determined by a single, dedicated breast pathologist were included in this study. Patients with multicentric disease (n = 122) or tumours spanning multiple quadrants (n = 381) were excluded from further analysis. Clinicopathological characteristics were analysed using chi-square tests for univariate analysis with multivariate analysis performed using principal components analysis (PCA) and multiple logistic regression. Significance was defined as P < 0.05. RESULTS: Of the 980 patients with defined tumour location, 30 had bilateral disease. Tumour location in the UOQ (51.5%) was significantly higher than in the UIQ (15.6%), LOQ (14.2%), central (10.6%), or LIQ (8.1%). Tumours in the central quadrant were significantly more likely to have higher tumour stage (P = 0.003) and size (P < 0.001), metastatic lymph nodes (P < 0.001), and mortality (P = 0.011). After multivariate analysis, only tumour size and lymph node status remained significantly associated with survival. CONCLUSIONS: Evaluation of tumour location as a prognostic factor revealed that although tumours in the central region are associated with less favourable outcome, these associations are not independent of location but rather driven by larger tumour size. Tumours in the central region are more difficult to detect mammographically, resulting in larger tumour size at diagnosis and thus less favourable prognosis. Together, these data demonstrate that tumour location is not an independent prognostic factor.
format Online
Article
Text
id pubmed-4531129
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Cancer Intelligence
record_format MEDLINE/PubMed
spelling pubmed-45311292015-08-17 Tumour location within the breast: Does tumour site have prognostic ability? Rummel, Seth Hueman, Matthew T Costantino, Nick Shriver, Craig D Ellsworth, Rachel E Ecancermedicalscience Research INTRODUCTION: Tumour location within the breast varies with the highest frequency in the upper outer quadrant (UOQ) and lowest frequency in the lower inner quadrant (LIQ). Whether tumour location is prognostic is unclear. To determine whether tumour location is prognostic, associations between tumour site and clinicopathological characteristics were evaluated. MATERIALS AND METHODS: All patients enrolled in the Clinical Breast Care Project whose tumour site—UOQ, upper inner quadrant (UIQ), central, LIQ, lower outer quadrant (LOQ)—was determined by a single, dedicated breast pathologist were included in this study. Patients with multicentric disease (n = 122) or tumours spanning multiple quadrants (n = 381) were excluded from further analysis. Clinicopathological characteristics were analysed using chi-square tests for univariate analysis with multivariate analysis performed using principal components analysis (PCA) and multiple logistic regression. Significance was defined as P < 0.05. RESULTS: Of the 980 patients with defined tumour location, 30 had bilateral disease. Tumour location in the UOQ (51.5%) was significantly higher than in the UIQ (15.6%), LOQ (14.2%), central (10.6%), or LIQ (8.1%). Tumours in the central quadrant were significantly more likely to have higher tumour stage (P = 0.003) and size (P < 0.001), metastatic lymph nodes (P < 0.001), and mortality (P = 0.011). After multivariate analysis, only tumour size and lymph node status remained significantly associated with survival. CONCLUSIONS: Evaluation of tumour location as a prognostic factor revealed that although tumours in the central region are associated with less favourable outcome, these associations are not independent of location but rather driven by larger tumour size. Tumours in the central region are more difficult to detect mammographically, resulting in larger tumour size at diagnosis and thus less favourable prognosis. Together, these data demonstrate that tumour location is not an independent prognostic factor. Cancer Intelligence 2015-07-13 /pmc/articles/PMC4531129/ /pubmed/26284116 http://dx.doi.org/10.3332/ecancer.2015.552 Text en © the authors; licensee ecancermedicalscience. http://creativecommons.org/licenses/by/3.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Rummel, Seth
Hueman, Matthew T
Costantino, Nick
Shriver, Craig D
Ellsworth, Rachel E
Tumour location within the breast: Does tumour site have prognostic ability?
title Tumour location within the breast: Does tumour site have prognostic ability?
title_full Tumour location within the breast: Does tumour site have prognostic ability?
title_fullStr Tumour location within the breast: Does tumour site have prognostic ability?
title_full_unstemmed Tumour location within the breast: Does tumour site have prognostic ability?
title_short Tumour location within the breast: Does tumour site have prognostic ability?
title_sort tumour location within the breast: does tumour site have prognostic ability?
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4531129/
https://www.ncbi.nlm.nih.gov/pubmed/26284116
http://dx.doi.org/10.3332/ecancer.2015.552
work_keys_str_mv AT rummelseth tumourlocationwithinthebreastdoestumoursitehaveprognosticability
AT huemanmatthewt tumourlocationwithinthebreastdoestumoursitehaveprognosticability
AT costantinonick tumourlocationwithinthebreastdoestumoursitehaveprognosticability
AT shrivercraigd tumourlocationwithinthebreastdoestumoursitehaveprognosticability
AT ellsworthrachele tumourlocationwithinthebreastdoestumoursitehaveprognosticability